Precigen (PGEN) Enterprise Value (2016 - 2025)

Precigen (PGEN) has disclosed Enterprise Value for 14 consecutive years, with -$106.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Enterprise Value fell 273.07% to -$106.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$254.3 million, a 788.09% decrease, with the full-year FY2024 number at -$69.7 million, down 10.88% from a year prior.
  • Enterprise Value was -$106.8 million for Q3 2025 at Precigen, down from -$15.1 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$15.1 million in Q2 2025 to a low of -$115.3 million in Q2 2022.
  • A 5-year average of -$60.9 million and a median of -$62.6 million in 2022 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: surged 61.18% in 2024, then plummeted 273.07% in 2025.
  • Precigen's Enterprise Value stood at -$72.2 million in 2021, then surged by 33.28% to -$48.2 million in 2022, then crashed by 30.41% to -$62.9 million in 2023, then decreased by 10.88% to -$69.7 million in 2024, then tumbled by 53.26% to -$106.8 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Enterprise Value are -$106.8 million (Q3 2025), -$15.1 million (Q2 2025), and -$44.7 million (Q1 2025).